This indicates that the capacity of CDK4/6i‐induced senescence to activate anti‐tumor immunity is probably similar to that of DNA‐damaging agent‐induced senescence, despite the reduced secretion of pro‐inflammatory and pro‐angiogenic SASP in the CDK4/6i‐group. The gene discussed is CDK4; the disease is neoplasm.